Prognosis and results after resection of very large (≥ 10 cm) hepatocellular carcinoma

Journal of Gastrointestinal Surgery

Volumn 11, Issue 5, 2007, Pages 589-595

  Shah, Shimul A ^a,b   Wei, Alice C ^a   Cleary, Sean P ^a   Yang, Ilun ^a   McGilvray, Ian D ^a   Gallinger, Steven ^a   Grant, David R ^a   Greig, Paul D ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Ablation; Hepatocellular carcinoma; Liver transplant; Recurrence; Resection; Vascular invasion

Indexed keywords

ARTICLE; CANCER INVASION; COHORT ANALYSIS; COMPARATIVE STUDY; DIAPHRAGM; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; INFERIOR CAVA VEIN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDY; RISK FACTOR; STERNUM; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE; VASCULAR TUMOR;

CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DIAPHRAGM; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; STERNUM; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR NEOPLASMS; VENA CAVA, INFERIOR;

EID: 34247551837     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-007-0154-7     Document Type: Article

References (38)

1. El Serag H B, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
2. Amin J, Dore GJ, O'connell DL, Bartlett M, Tracey E, Kaldor JM, Law MG. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol 2006;45:197-203.
3. Taura N, Yatsuhashi H, Hamasaki K, Nakao K, Daikoku M, Ueki T, Yano K, Matsumoto T, Ishibashi H, Eguchi K. Increasing hepatitis C virus-associated hepatocellular carcinoma mortality and aging: Long term trends in Japan. Hepatol Res 2006;88:35-55.
4. Monnet E, Collin-Naudet E, Bresson-Hadni S, Minello A, Di Martino V, Carel D, Jooste V, Gagnaire A, Evrard P, Obert-Clerc B, Miguet JP, Hillon P. Place of residence and distance to medical care influence the diagnosis of hepatitis C: a population-based study. J Hepatol 2006;44:499-506.
5. Shah SA, Greig PD, Gallinger S, Cattral MS, Dixon E, Kim RD, Taylor BR, Grant DR, Vollmer CM. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 2006;202:275-283.
6. Regimbeau JM, Abdalla EK, Vauthey JN, Lauwers GY, Durand F, Nagomey DM, Ikai I, Yamaoka Y, Belghiti J. Risk factors for early death due to recurrence after liver resection for hepatocel lular carcinoma: results of a multicenter study. J Surg Oncol 2004;85:36-41.
7. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, Yamaoka Y, Belghiti J, Lauwers GY, Poon RT, Abdalla EK, Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 2005;11:1086-1092.
8. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005;25:181-200.
9. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
10. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, Pompili M, Brunello F, Lazzaroni S, Torzilli G. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101-108.
11. Harada T, Matsuo K, Inoue T, Tamesue S, Inoue T, Nakamura H. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg 1996;224:4-9.
12. Pawlik TM, Poon RT, Abdalla EK, Zorzi D, Ikai I, Curley SA, Nagorney DM, Belghiti J, Ng IO, Yamaoka Y, Lauwers GY, Vauthey JN, Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 2005;140:450-457.
13. Liau KH, Ruo L, Shia J, Padela A, Gonen M, Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH, Dematteo RP. Outcome of partial hepatectomy for large (>10 cm) hepatocellular carcinoma. Cancer 2005;104:1948-1955.
14. Poon RT, Fan ST, Wong J. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg 2002;194:592-602.
15. Fong Y, Sun RL, Jamagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999;229:790-799.
16. Yeh CN, Lee WC, Chen MF. Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung memorial hospital. Ann Surg Oncol 2003;10:1070-1076.
17. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
18. Hemming AW, Gallinger S, Greig PD, Cattral MS, Langer B, Taylor BR, Verjee Z, Giesbrecht E, Nakamachi Y, Furuya KN. The hippurate ratio as an indicator of functional hepatic reserve for resection of hepatocellular carcinoma in cirrhotic patients. J Gastrointest Surg 2001;5:316-321.
19. Levy I, Greig PD, Gallinger S, Langer B, Sherman M. Resection of hepatocellular carcinoma without preoperative tumor biopsy. Ann Surg 2001;234:206-209.
20. Pawlik TM, Poon RT, Abdalla EK, Zorzi D, Ikai I, Curley SA, Nagorney DM, Belghiti J, Ng IO, Yamaoka Y, Lauwers GY, Vauthey JN. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 2005;140:450-457.
21. Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller CM, Gondolesi GE, Krieger NR, Schwartz ME. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 2004;10:534-540.
22. Ng KK, Vauthey JN, Pawlik TM, Lauwers GY, Regimbeau JM, Belghiti J, Ikai I, Yamaoka Y, Curley SA, Nagorney DM, Ng IO, Fan ST, Poon RT. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 2005;12;364-373.
23. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004;240:698-708.
24. Dimick JB, Cowan JA, Jr., Knol JA, Upchurch GR, Jr. Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg 2003;138:185-191.
25. Schwartz M, Roayaie S, Llovet J. How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated? J Hepatol 2005;43:584-589.
26. Poon RT, Fan ST, Ng IO, Wong J. Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassification. Ann Surg 2003;237:376-383.
27. Nagano Y, Togo S, Tanaka K, Matsuo K, Sugita M, Morioka D, Endo I, Sekido H, Shimada H. The role of median sternotomy in resections for large hepatocellular carcinomas. Surgery 2005;137:104-108.
28. Liu CL, Fan ST, Lo CM, Tung-Ping PR, Wong J. Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg 2000;232:25-31.
29. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-1403.
30. Gondolesi GE, Roayaie S, Munoz L, Kim-Schluger L, Schiano T, Fishbein TM, Emre S, Miller CM, Schwartz ME. Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg 2004;239:142-149.
31. Roayaie S, Llovet JM. Liver transplantation for hepatocellular carcinoma: is expansion of criteria justified? Clin Liver Dis 2005; 9:315-328.
32. Wakabayashi H, Ishimura K, Okano K, Izuishi K, Karasawa Y, Goda F, Maeba T, Maeta H. Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced-stage hepatocellular carcinoma? Cancer 2001;92:2384-2390.
33. Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ, P'eng FK. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 1995;82:122-126.
34. Yamasaki S, Hasegawa H, Kinoshita H, Furukawa M, Imaoka S, Takasaki K, Kakumoto Y, Saitsu H, Yamada R, Oosaki Y, Arii S, Okamoto E, Monden M, Ryu M, Kusano S, Kanematsu T, Ikeda K, Yamamoto M, Saoshiro T, Tsuzuki T. A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 1996;87:206-211.
35. Shoup M, Gonen M, D'Angelica M, Jarnagin WR, Dematteo RP, Schwartz LH, Tuorto S, Blumgart LH, Fong Y. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 2003;7:325-330.
36. Nagano Y, Tanaka K, Togo S, Matsuo K, Kunisaki C, Sugita M, Morioka D, Miura Y, Kubota T, Endo I, Sekido H, Shimada H. Efficacy of hepatic resection for hepatocellular carcinomas larger than 10 cm. World J Surg 2005;29:66-71.
37. Fong Y, Bentrem DJ, CASH (Chemotherapy-associated Steatohepatitis) costs. Ann Surg 2006;243:8-9.
38. Covey AM, Tuorto S, Brody LA, Sofocleous CT, Schubert J, Tengg-Kobligk H, Getrajdman GI, Schwartz LH, Fong Y, Brown KT. Safety and efficacy of preoperative portal vein embolization with polyvinyl alcohol in 58 patients with liver metastases. AJR Am J Roentgenol 2005;185:1620-1626.